Clinical Trial Update: Single-arm Phase II Study of NDURE for Patients With HNC [NA]

View source ↗

Summary

Phase II single-arm trial of NDURE in patients with cancer of the head and neck has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• NDURE

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cancer of Head and Neck | NA | Status: COMPLETED | Results posted: 2021-02-01